MiNK Therapeutics is a biopharmaceutical company focusing on the development of innovative RNA-based therapies for the treatment of genetic diseases. With a commitment to cutting-edge research and a strong pipeline of potential breakthrough treatments, MiNK Therapeutics is poised to make a significant impact in the field of precision medicine.
